Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

36.22
-0.2600-0.71%
Post-market: 36.16-0.0600-0.17%18:44 EST
Volume:2.99M
Turnover:106.01M
Market Cap:3.81B
PE:41.47
High:38.22
Open:37.65
Low:33.94
Close:36.48
52wk High:117.33
52wk Low:28.66
Shares:105.19M
Float Shares:86.88M
Volume Ratio:0.79
T/O Rate:3.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8735
EPS(LYR):1.23
ROE:16.70%
ROA:5.10%
PB:6.03
PE(LYR):29.45

Loading ...

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 20

Corcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright

TIPRANKS
·
Feb 20

BRIEF-Corcept Says US Court Rules Teva's Generic Korlym Does Not Infringe Corcept Patents

Reuters
·
Feb 20

Corcept Therapeutics Inc - Ruling Affirms December 2023 Verdict by Federal District Court

THOMSON REUTERS
·
Feb 20

Corcept Therapeutics Inc - Considering Judicial Review of Court Decision

THOMSON REUTERS
·
Feb 20

Corcept Provides Update on Patent Dispute With Teva Pharmaceuticals

THOMSON REUTERS
·
Feb 20

Corcept Therapeutics Stock Plunges As Court Clears Teva Generic

Benzinga
·
Feb 20

Corcept Therapeutics Down 21%: Why Is CORT Stock Crashing Today?

TIPRANKS
·
Feb 20

Corcept Therapeutics trading halted, volatility trading pause

TIPRANKS
·
Feb 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM

Reuters
·
Feb 19

How FDA Relacorilant Setback and Legal Probes Will Impact Corcept Therapeutics (CORT) Investors

Simply Wall St.
·
Feb 18

Corcept Therapeutics Incorporated to Announce Financial Results and Host Conference Call

Reuters
·
Feb 18

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call

THOMSON REUTERS
·
Feb 18

High Insider Ownership Fuels Growth Stocks In February 2026

Simply Wall St.
·
Feb 12

Chief Development Officer William Guyer Reports Disposal of Corcept Therapeutics Common Shares

Reuters
·
Feb 06

Corcept falls as FDA reveals it warned of CRL rejection for relacorilant

TIPRANKS
·
Jan 31

Corcept Therapeutics Shares Down 16% After FDA Rejection Letter Reveals Repeated Warnings

THOMSON REUTERS
·
Jan 30

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

Reuters
·
Jan 30

BUZZ-Corcept tumbles after FDA rejection letter reveals repeated warnings

Reuters
·
Jan 30

Top Growth Companies With High Insider Ownership In January 2026

Simply Wall St.
·
Jan 26